Nutrient supply, cell spatial correlation and Gompertzian tumor growth
P Castorina1,2,3, D Carco'4
1Istituto Oncologico del Mediterraneo, Viagrande, Italy. paolo.castorina@ct.infn.it.
Summary
Gompertzian tumor growth models require more than just energy constraints, incorporating cell spatial correlations and nutrient supply for accurate in vivo predictions. This study reveals how local cell interactions explain growth limitations and parameter interdependence in tumors.
Area of Science:
- Mathematical Biology
- Tumor Growth Dynamics
- Cellular Biophysics
Background:
- Gompertzian tumor growth is a widely used model.
- Existing models often focus on global energy constraints.
- In vivo data suggests limitations not fully explained by energy alone.
Purpose of the Study:
- To investigate the role of local spatial cell correlations in Gompertzian tumor growth.
- To determine if nutrient supply and cell activities influence growth dynamics.
- To explain the interdependence of Gompertz growth parameters.
Main Methods:
- Modeling tumor growth using mitosis and nutrient supply considerations.
- Analyzing local spatial cell correlations and network structures.
- Evaluating global energy constraints against in vivo data.
Main Results:
- Global energy constraints alone cannot reproduce observed in vivo tumor growth data.
- Local spatial cell correlations, including mean-field and small-world networks, successfully reproduce Gompertzian growth.
- The interdependence between Gompertz growth parameters naturally arises from cell volume and tumor density.
Conclusions:
- Local cell interactions and nutrient dynamics are crucial for accurate tumor growth modeling.
- Spatial correlations provide a mechanism for the depletion of exponential growth observed in tumors.
- Tumor density and cell size are key factors influencing Gompertz growth parameter interdependence.
More Related Videos
08:50Longitudinal Morphological and Physiological Monitoring of Three-dimensional Tumor Spheroids Using Optical Coherence Tomography
Published on: February 9, 2019
7.9K
07:41Three-dimensional Cell Culture Model for Measuring the Effects of Interstitial Fluid Flow on Tumor Cell Invasion
Published on: July 25, 2012
16.9K
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
6.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
02:17The Tumor Microenvironment
7.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K
02:36Cells Coordinate Growth and Proliferation
4.7K
Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
4.7K
03:03mTOR Signaling and Cancer Progression
4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.0K
02:07Tumor Progression
6.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K
01:22PI3K/mTOR/AKT Signaling Pathway
4.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.3K